Integer Holdings Co. (NYSE:ITGR) Short Interest Down 14.2% in May

Integer Holdings Co. (NYSE:ITGR - Get Free Report) was the target of a large decrease in short interest in May. As of May 15th, there was short interest totalling 2,850,000 shares, a decrease of 14.2% from the April 30th total of 3,320,000 shares. Based on an average trading volume of 658,900 shares, the short-interest ratio is currently 4.3 days. Currently, 8.7% of the shares of the stock are short sold.

Integer Trading Up 0.3%

ITGR stock traded up $0.35 during trading on Friday, hitting $121.25. The company had a trading volume of 234,023 shares, compared to its average volume of 374,325. Integer has a 52-week low of $104.93 and a 52-week high of $146.36. The company has a 50 day simple moving average of $118.75 and a 200-day simple moving average of $128.20. The firm has a market capitalization of $4.23 billion, a P/E ratio of 36.09, a PEG ratio of 1.72 and a beta of 1.03. The company has a quick ratio of 2.09, a current ratio of 2.95 and a debt-to-equity ratio of 0.62.

Integer (NYSE:ITGR - Get Free Report) last posted its quarterly earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, beating the consensus estimate of $1.27 by $0.04. Integer had a net margin of 6.92% and a return on equity of 11.65%. The firm had revenue of $437.39 million during the quarter, compared to the consensus estimate of $428.51 million. During the same quarter in the previous year, the firm posted $1.14 earnings per share. The company's revenue was up 7.3% on a year-over-year basis. As a group, research analysts forecast that Integer will post 6.01 earnings per share for the current fiscal year.

Analysts Set New Price Targets

ITGR has been the topic of several recent research reports. Oppenheimer cut shares of Integer from an "outperform" rating to a "market perform" rating in a research report on Friday, February 21st. Raymond James raised their price objective on Integer from $145.00 to $150.00 and gave the company an "outperform" rating in a research note on Friday, April 25th. KeyCorp cut their target price on Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. Citigroup upgraded Integer from a "hold" rating to a "strong-buy" rating and raised their price target for the stock from $133.00 to $140.00 in a research report on Thursday, May 22nd. Finally, Wall Street Zen upgraded shares of Integer from a "sell" rating to a "hold" rating in a research report on Monday, May 19th. Two investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $145.00.

Insider Transactions at Integer

In related news, CEO Joseph W. Dziedzic sold 338,975 shares of the business's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $123.17, for a total value of $41,751,550.75. Following the sale, the chief executive officer now owns 47,000 shares in the company, valued at approximately $5,788,990. The trade was a 87.82% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 2.16% of the company's stock.

Institutional Trading of Integer

Institutional investors and hedge funds have recently made changes to their positions in the company. Mather Group LLC. lifted its position in shares of Integer by 304.3% in the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 143 shares during the period. Lee Danner & Bass Inc. purchased a new position in shares of Integer in the 4th quarter valued at approximately $27,000. Opal Wealth Advisors LLC acquired a new stake in Integer in the 1st quarter worth approximately $28,000. AdvisorNet Financial Inc purchased a new stake in Integer during the 1st quarter worth approximately $28,000. Finally, SVB Wealth LLC purchased a new position in Integer in the 1st quarter worth $35,000. 99.29% of the stock is currently owned by institutional investors.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.